BioCryst Pharmaceuticals SG&A Expense (Quarterly) Trends

BioCryst Pharmaceuticals Inc (BCRX)

7.62 +0.04 (+0.53%) USD | NASDAQ | Sep 27, 16:00

7.62 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.

Date	Value
June 30, 2024	61.21M
March 31, 2024	59.36M
December 31, 2023	64.38M
September 30, 2023	50.65M
June 30, 2023	51.00M
March 31, 2023	47.87M
December 31, 2022	50.15M
September 30, 2022	36.92M
June 30, 2022	38.02M
March 31, 2022	34.28M
December 31, 2021	35.39M
September 30, 2021	34.99M
June 30, 2021	26.32M
March 31, 2021	22.11M
December 31, 2020	20.99M
September 30, 2020	17.20M
June 30, 2020	13.88M
March 31, 2020	15.86M
December 31, 2019	10.49M
September 30, 2019	11.74M
June 30, 2019	8.659M
March 31, 2019	6.238M
December 31, 2018	4.49M
September 30, 2018	7.923M
June 30, 2018	9.492M

Date	Value
March 31, 2018	7.609M
December 31, 2017	4.698M
September 30, 2017	3.343M
June 30, 2017	2.834M
March 31, 2017	3.058M
December 31, 2016	2.561M
September 30, 2016	2.756M
June 30, 2016	2.724M
March 31, 2016	3.212M
December 31, 2015	2.721M
September 30, 2015	2.731M
June 30, 2015	3.534M
March 31, 2015	4.061M
December 31, 2014	2.048M
September 30, 2014	1.812M
June 30, 2014	2.013M
March 31, 2014	1.588M
December 31, 2013	1.418M
September 30, 2013	1.579M
June 30, 2013	1.432M
March 31, 2013	1.578M
December 31, 2012	4.233M
September 30, 2012	1.591M
June 30, 2012	1.609M
March 31, 2012	1.697M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

10.49M

Minimum

Dec 2019

64.38M

Maximum

Dec 2023

35.14M

Average

35.19M

Median

SG&A Expense (Quarterly) Benchmarks